KPV: Potent Anti-Inflammatory Tripeptide

Research on the alpha-MSH derived peptide for inflammation and gut health

Source: https://indexalabs.com/blog/kpv-anti-inflammatory-peptide-research Abstract: KPV (Lys-Pro-Val) is a tripeptide derived from alpha-melanocyte stimulating hormone (α-MSH) that retains potent anti-inflammatory activity without melanotropic effects. This guide covers its unique properties and research applications.

1. Overview

KPV represents the C-terminal tripeptide of α-MSH responsible for the hormone’s anti-inflammatory effects. By isolating this fragment, researchers can study anti-inflammatory mechanisms without the tanning and appetite effects of full α-MSH.

2. Mechanisms of Action

2.1 NF-κB Inhibition KPV directly inhibits NF-κB nuclear translocation, reducing inflammatory gene transcription.

2.2 Cytokine Modulation Reduces production of pro-inflammatory cytokines including TNF-α, IL-1β, and IL-6.

2.3 Cell Penetration Uniquely, KPV can enter cells directly, providing intracellular anti-inflammatory action.

2.4 Gut Barrier Research shows particular efficacy in intestinal inflammation and barrier function.

3. Research Applications

3.1 Inflammatory Bowel Disease Extensive research in colitis and Crohn’s disease models.

3.2 Skin Inflammation Studies on dermatitis, psoriasis, and inflammatory skin conditions.

3.3 Wound Healing Anti-inflammatory support for tissue repair research.

3.4 Systemic Inflammation Research on systemic inflammatory conditions.

4. Research Protocols

4.1 Available Sizes KPV is available in 10mg vials.

4.2 Oral Stability Unlike most peptides, KPV shows activity with oral administration, particularly for gut applications.

4.3 Combination Use Often combined with tissue repair peptides for comprehensive healing protocols.